Key result
Intravenous endothelin-1 induced a more prominent reduction in cardiac output compared to angiotensin I and phenylephrine in conscious Milan normotensive rats.
Why the study?
Does intravenous endothelin-1 affect hemodynamics and cardiac contractility differently than angiotensin I and phenylephrine in conscious Milan normotensive rats?
Does intravenous endothelin-1 affect hemodynamics and cardiac contractility differently than angiotensin I and phenylephrine in conscious Milan normotensive rats?
Endothelin-1 produces a more prominent reduction in cardiac output and left ventricular performance compared to angiotensin I and phenylephrine in normotensive rats, likely due to reduced diastolic filling volume.
Answers are grounded in this paper and cite their sources.
Endothelin-1 may uniquely impair cardiac output in this rat model; leaves open translation to human hemodynamics or therapy.
The effects of endothelin-1 (ET-1) on hemodynamics and cardiac contractility were compared with the responses to angiotensin I (AI) and phenylephrine (PE) in Milan normotensive rats. Intravenous (i.v.) injection of ET-1 (0.8 nmol/kg) initially decreased mean blood pressure (MBP), total peripheral resistance (TPR), and dP/dt (-28 +/- 2, -34.8 +/- 3.7, and -9.4 +/- 1.3%, p less than 0.01, respectively), and increased heart rate (HR), cardiac output (CO), and the velocity of myocardial anterior wall shortening (dL/dt) (11.8 +/- 2.1, 10.4 +/- 2.9, and 28.3 +/- 8.3% p less than 0.05, respectively). These effects were followed by a sustained increase in MBP and TPR and a decrease in CO. As compared with AI (0.25 nmol/kg) and PE (35 nmol/kg), which produced a similar degree of increase in TPR, the reduction in CO induced by ET-1 was more prominent (-25 +/- 2 by ET-1 vs. -14 +/- 2 by AI and -14 +/- 3% by PE, p less than 0.05, respectively). Moreover, ET-1 induced a significant decrease in dP/dt, shortening fraction (SF), and dL/dt (-6.1 +/- 1.6, -35.0 +/- 3.8, and -38.6 +/- 5.5%, p less than 0.01, respectively), whereas these indexes of left ventricle performance were not affected by either AI or PE. Furthermore, the reduction in SF induced by ET-1 was mainly due to the decrease in myocardial diastolic segment length, suggesting reduction in diastolic filling volume.(ABSTRACT TRUNCATED AT 250 WORDS)
No takes yet. Share an insight, caveat, or question.
Yang et al. (1991) studied Milan normotensive rats. Endothelin-1 (ET-1) vs. Angiotensin I (AI) and phenylephrine (PE) was evaluated on Reduction in cardiac output (CO) (p=<0.05). Intravenous endothelin-1 induced a more prominent reduction in cardiac output compared to angiotensin I and phenylephrine in conscious Milan normotensive rats.
Synapse has enriched 10 related papers. Consider them for comparative context: